Evidence map›Paper›PMID 41514598›Full record

ArticleCancers2025

Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis.

Bubse Na, Chang Hyun Kang, Taeyoung Yun, Ji Hyeon Park, Kwon Joong Na, Samina Park, Hyun Joo Lee, In Kyu Park, Young Tae Kim, Bhumsuk Keam and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bubse NaDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0002-3293-1446
Chang Hyun KangDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0002-1612-1937
Taeyoung YunDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0002-4303-8493
Ji Hyeon ParkDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Kwon Joong NaDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Samina ParkDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0001-9625-2672
Hyun Joo LeeDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.
In Kyu ParkDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0003-3550-5554
Young Tae KimDepartment of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0001-9006-4881
Bhumsuk KeamCancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-8196-4247
Hak Jae KimCancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

neoadjuvant chemoradiotherapyneoadjuvant chemotherapythymic carcinomathymoma

Identifiers

PMID41514598
PMCPMC12785132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.